Dental Tribune Indian Edition

8 Dental Tribune Indian Edition - April 2013 DTI LOMA LINDA, Calif., USA: The in dications and versatility of dental im plants have increased, and so have com plications. Researchers from the Loma Linda University School of Dentistry in the US have suggested that, regardless of patient risk factors like bruxism, successful longterm outcomes signifi cantly depend on the experience of the clinician performing the procedure. By reviewing the records of eden tulous patients who had received fullarch maxillary and/or mandi bular supported fixed complete den tures over a period of ten years, the researchers found that 12 percent of implants failed when clinicians had less than five years of experience in the field. Implants were also twice as likely to fail if the surgeon had perfor med less than 50 implantations in his career, they report. Other contributors to implant fai lure were identified as being related to the patient rather than the implant. Almost every third patient with diabe tes or a history of bruxism had expe rienced implant failure. Other risk factors commonly as sociated with implant failure like the type of prosthesis used, smoking or implant location were found to have less impact on longterm success, ac cording to the researchers. They sta ted that the absolute rate of success was found to be 90 percent. Overall, the records of 50 patients treated with 297 implants at the scho ol were reviewed.DT World News Dutch supplier acquired by SomnoMed Daniel Zimmermann DTI SYDNEY, Australia/ZURICH, Switzerland: SomnoMed has expan ded its own distribution network in Europe through a new acquisition. According to the terms of an agree ment closed between the Australian based company and Goedegebuure Slaaptechniek B.V. (GS) in Loenen aan de Vecht near Amsterdam, GS will market and distribute Somno Med’s range of dental solutions for the treatment of sleep breathing disorders exclusively in the Netherlands. Currently, GS is one of the leading Dutch suppliers of mandibular repo sitioning appliances. With the take over, SomnoMed intends to boost its presence and business development in Europe, particularly in important Central European markets, CEO Ralf Barschow said. He told Dental Tribune Asia Pacific that sales have jumpstar ted in the Netherlands because devices for the treatment of conditions like ob structive sleep apnoea syndrome have been reimbursed by the country’s he alth insurance companies since 2010. The acquisition will be paid half in cash and half in shares and is expected to be completed by 2019. SomnoMed stocks listed on the Australian Securi ties Exchange reacted positively to the announcement. According to Barschow, sales in Europe contribute approximately 25 per cent to SomnoMed’s global busi ness results. Last year, revenues in the region grew by over 30 percent. He confirmed that the company is also in talks with other suppliers in Eu rope. Since 2008, the company has been operating actively in Europe through its subsidiary in Zurich in Switzerland.DT The SomnoDent MSA device has seen increasing sales in the Netherlands. (DTI/Photo SomnoMed, Switzerland) US study suggests dentists cause implant failure Dentists with little experience contribute to failures of the device. To be successful internationally for 20 years is quite a remarkable achie vement for a temporary crown and bridge material. But DMG’s Luxa temp can lay claim to that. The bisa cryl composite, on the market for the past two decades, can look back on a long history of the highest accola des. Multiawardwinning Luxatemp Fluorescence, predecessor of today’s Luxatemp Star, was acclaimed Top Provisional Material and Best of the Best*. And the new generation has already been awarded the highest possible rating of 5 stars by REALI TY, an independent testing lab in the USA**. Luxatemp Star garners top marks in break resistance and flexural strength, ensuring dependable stability and durability. Longterm shade stabili ty has also been optimized. What’s more, Luxatemp Star attains its final hardness in just 5 minutes, making it even faster than its predecessor. Find out more about Luxatemp from your official DMG dealer or see www.dmgdental.com/20years. * The Dental Advisor, Vol. 28, No. 01 Jan/Feb 2011, Pg. 9 *REALITY now, Oct2011,No.228,Pg.1 Luxatemp Star is sold in the USA as “Luxatemp Ultra” and was also tested under this name. DMG Elbgaustraße 248 22547 Hamburg Telephone: +49 (0) 40 84 0060 info@dmgdental.com www.dmgdental.com 20 Years Luxatemp–a successful material celebrates its anniversary